Shariah compliance overview
Not HalalCapricor Therapeutics, Inc. (CAPR) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death…
Capricor Therapeutics, Inc. (CAPR) operates in the Healthcare sector, in the Biotechnology industry.
Why it is not classified as halal: it does not pass these screens: Business Activity, Interest-bearing securities and assets.
- Business Activity
- 100.00%Limit 5%Fail
- Interest-bearing debt
- 0.59%Limit 30%Pass
- Interest-bearing securities and assets
- 51.92%Limit 30%Fail
- Dividend purification
- 100.00%Share of dividends to give to charityPurification calculator
Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Capricor Therapeutics, Inc. (CAPR). Current Akinda screening label: Not Halal.
